Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Head & Neck 1

Conditions

Breast Neoplasms 58Lung Neoplasms 31Colorectal Neoplasms 25Prostatic Neoplasms 22Colonic Neoplasms 17Carcinoma, Non-Small-Cell Lung 16Uterine Cervical Neoplasms 15Rectal Neoplasms 15Neoplasms 13Lymphoma 11Depression 10Urinary Bladder Neoplasms 9Unspecified Adult Solid Tumor, Protocol Specific 9Endometrial Neoplasms 9Leukemia 8Hematologic Neoplasms 8Fatigue 8Breast Carcinoma In Situ 8Anxiety Disorders 8Pancreatic Neoplasms 7Pain 7Ovarian Neoplasms 7Leukemia, Myeloid, Acute 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Obesity 6Multiple Myeloma 6Melanoma 6Small Cell Lung Carcinoma 5Papillomavirus Infections 5Neoplasm Metastasis 5

Interventions

Radiotherapy 9Cisplatin 8Fibroblast Growth Factor 7 6Low-Level Light Therapy 5angiotensin I (1-7) 4Radiation 4Injections 4Propolis 3Morphine 3Methotrexate 3Leucovorin 3Drug Therapy 3Cryotherapy 3glucarpidase 2aluminum hydroxide, magnesium hydroxide, drug combination 2Xylitol 2Water 2Radiotherapy, Intensity-Modulated 2RRx-001 2Probiotics 2Pentoxifylline 2Mouthwashes 2Melphalan 2Lidocaine 2Ketamine 2Interleukin 1 Receptor Antagonist Protein 2Honey 2Glutamine 2Gabapentin 2Fluorouracil 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Mucositis × Early Intervention, Educational × Clear all
NCT02480114 2021-02-18

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
79 enrolled 8 charts
Head & NeckOther

Abnormalities, Radiation-Induced, Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡